PAR-21-118 - NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| NHLBI Announces Interest in Promoting Cardiovascular and Cardiometabolic Health in Early Stages of the Lifecourse: Pre-adolescence Through Adolescence to Young Adulthood | NOT-HL-21-020 | NHLBI | Aug 30, 2021 | Apr 13, 2026 | R34, R61/R33, UG3/UH3, U24 |
For technical issues E-mail OER Webmaster